PTEN and neoplasm: We recently showed that deletion of Prl2 in a Pten heterozygous background results in PTEN augmentation and impedes Pten deficiency–induced spontaneous tumorigenesis by inhibiting tumor cell proliferation and promoting their apoptosis (9).